These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2004052)

  • 1. Anti-Kell in pregnancy.
    Leggat HM; Gibson JM; Barron SL; Reid MM
    Br J Obstet Gynaecol; 1991 Feb; 98(2):162-5. PubMed ID: 2004052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kell sensitization in pregnancy.
    Caine ME; Mueller-Heubach E
    Am J Obstet Gynecol; 1986 Jan; 154(1):85-90. PubMed ID: 3946507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Haemolytic disease of the newborn--from a mother with anti-Kell, anti-E and anti-Vel anti-erythrocyte alloantibodies].
    Vućinović M; Jadrić H; Karelović D; Roje D; Haspl-Hundrić Z; Hrgović Z; Vućinović Z
    Z Geburtshilfe Neonatol; 2004 Oct; 208(5):197-202. PubMed ID: 15508054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal Kell blood group alloimmunization.
    Bowman JM; Pollock JM; Manning FA; Harman CR; Menticoglou S
    Obstet Gynecol; 1992 Feb; 79(2):239-44. PubMed ID: 1731292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obstetric outcome after RhD and Kell testing.
    Lipitz S; Many A; Mitrani-Rosenbaum S; Carp H; Frenkel Y; Achiron R
    Hum Reprod; 1998 Jun; 13(6):1472-5. PubMed ID: 9688374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-anti-D antibodies in red-cell alloimmunization.
    Moise KJ
    Eur J Obstet Gynecol Reprod Biol; 2000 Sep; 92(1):75-81. PubMed ID: 10986438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of anti-Kell sensitization in pregnancy.
    Mayne KM; Bowell PJ; Pratt GA
    Clin Lab Haematol; 1990; 12(4):379-85. PubMed ID: 2081378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting anti-Kell-mediated hemolytic disease of the fetus and newborn: diagnostic accuracy of laboratory management.
    Slootweg YM; Lindenburg IT; Koelewijn JM; Van Kamp IL; Oepkes D; De Haas M
    Am J Obstet Gynecol; 2018 Oct; 219(4):393.e1-393.e8. PubMed ID: 30063902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal determination of genotypes Kell and Cellano in at-risk pregnancies.
    Spence WC; Maddalena A; Demers DB; Bick DP
    J Reprod Med; 1997 Jun; 42(6):353-7. PubMed ID: 9219123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of pregnancies complicated by anti-Kell isoimmunization.
    McKenna DS; Nagaraja HN; O'Shaughnessy R
    Obstet Gynecol; 1999 May; 93(5 Pt 1):667-73. PubMed ID: 10912964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemolytic disease of newborn.
    Narang A; Jain N
    Indian J Pediatr; 2001 Feb; 68(2):167-72. PubMed ID: 11284186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kell hemolytic disease of the newborn: A case for expanded prenatal antibody screening.
    Spivey MA; Wilson JT; Taylor HL
    J Ark Med Soc; 1978 Jul; 75(2):73-5. PubMed ID: 149785
    [No Abstract]   [Full Text] [Related]  

  • 13. [The passage of maternal rhesus antibodies into the amniotic fluid and its clinical significance].
    Hoffbauer H
    Z Geburtshilfe Gynakol; 1967 Feb; 166(3):290-301. PubMed ID: 4969772
    [No Abstract]   [Full Text] [Related]  

  • 14. Haemolytic disease of the newborn due to anti-K antibodies.
    de Jonge N; Martens JE; Milani AL; Krijnen JL; van Krimpen C; Ponjee GA
    Eur J Obstet Gynecol Reprod Biol; 1996 Jul; 67(1):69-72. PubMed ID: 8789754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of hemolytic disease of the newborn caused by anti-Kell antibody with recombinant erythropoietin.
    Dhodapkar KM; Blei F
    J Pediatr Hematol Oncol; 2001 Jan; 23(1):69-70. PubMed ID: 11196277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Kell antibodies in pregnancy].
    Rempen A; Schweppe KW
    Z Geburtshilfe Perinatol; 1983; 187(4):183-90. PubMed ID: 6684844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Perinatal research on feto-maternal anti-Kell immunization].
    Gavriil P; Jauniaux E; Lambermont M; Donner C; Avni FE; Rodesch F
    J Gynecol Obstet Biol Reprod (Paris); 1989; 18(6):761-4. PubMed ID: 2689503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative and functional asessment of anti-RhD: a comparative study of non-invasive methods in antenatal prediction of Rh hemolytic disease.
    Filbey D; Garner SF; Hadley AG; Shepard SL
    Acta Obstet Gynecol Scand; 1996 Feb; 75(2):102-7. PubMed ID: 8604593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The outcome of pregnancy in Kell alloimmunisation.
    Grant SR; Kilby MD; Meer L; Weaver JB; Gabra GS; Whittle MJ
    BJOG; 2000 Apr; 107(4):481-5. PubMed ID: 10759266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Death in utero due to Kell sensitization without excessive elevation of the delta OD450 value in amniotic fluid.
    Berkowitz RL; Beyth Y; Sadovsky E
    Obstet Gynecol; 1982 Dec; 60(6):746-9. PubMed ID: 7145281
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.